Showing 2461-2470 of 2726 results for "".
- FDA Clears Wontech’s Sandro Dual Laserhttps://modernaesthetics.com/news/fda-clears-wontechs-sandro-dual-laser/2472905/The U.S. Food and Drug Administration granted 510 (K) marketing clearance to Wontech’s Sandro Dual, a hybrid Nd:YAG & Alexandrite laser device. In the hybrid mode, by irradiating a short time difference between two wavelengths of 755nm and 1064nm, the laser accurately hits its
- Industry Responds to COVID-19: E.T. Browne Drug Co., RealSelf, HydraFacial, Thrive Causemeticshttps://modernaesthetics.com/news/industry-responds-to-covid-19-dermyoung-coty-leo-pharma/2472903/E.T. Browne Drug Co. The manufacturer of Palmer' Cocoa Butter Formula and Coconut Oil Formula skin and hair care products is now producing medical-grade hand sanitizer to address widespread supply shortages in the wake of COVID-19. Initial production of the disinfectant sanit
- Facial Plastic Surgeons Respond to COVID-19: “We Will Get Through This...Whatever It Takes”https://modernaesthetics.com/news/facial-plastic-surgeons-respond-to-covid-19-we-will-get-through-thiswhatever-it-takes/2472902/All health care professionals are doing what they can to help Americans cope with the COVID-19 pandemic. For facial plastic surgeons, COVID-19 has caused an upheaval in their professional lives with office closures and the postponement of all elective procedures. The CARES Act is h
- Survey Explores Negative Impact of COVID-9, Economic Fallout on Jobshttps://modernaesthetics.com/news/survey-explores-negative-impact-of-covid-9-economic-fallout-on-jobs/2472899/While 35 percent of 1,000 Americans surveyed by LendEDU say that that their jobs have not been impacted by the Coronavirus, six percent report losing their job, 13 percent report that hours have been partially cut, and 11 percent have had hours cut entirely, though they still have their jobs.
- Meet Zaffiro, Neauvia’s Two-Part Solution to Skin Rejuvenationhttps://modernaesthetics.com/news/meet-zaffiro-neuvias-two-part-solution-to-skin-rejuvenation/2472893/Neauvia introduced Zaffiro to the media at an event held in New York City’s Hudson Yards, featuring New York City dermatologist Amy Lewis, MD Launched in the US in late 2019, the Zaffiro device is a dual facial rejuvenation system combining wa
- Dermatologists React to Threat of Coronavirus Pandemichttps://modernaesthetics.com/news/dermatologists-react-to-threat-of-coronavirus-pandemic-1/2472891/Reports about COVID-19 are causing many dermatologists and aesthetic physicians to rethink their travel plans and update their office policy on the care of sick patients. The International Health Regulations Emergency Committee of the World Health Organization declared the outbreak a &l
- Lumenis Launches Stellar M22 Platformhttps://modernaesthetics.com/news/lumenis-launches-stellar-m22-platform/2472890/Lumenis Ltd. is launching the Stellar M22, a multi-application platform that builds on the heritage of the M22 by adding even more bells and whistles. The new Stellar M22 is now available in the USA and Europe. "Lu
- Cynosure Launches Potenza RF Microneedling Devicehttps://modernaesthetics.com/news/cynosure-launches-potenza-rf-microneedling-device/2472886/The U.S. Food and Drug Administration (FDA) cleared Cynosure’s Potenza, a four-mode radiofrequency (RF) microneedling device. The Potenza device comprises four modes (monopolar or bipolar, delivered at either 1 MHz or 2 MHz frequency)
- FDA Sets November PDUFA Date for DaxibotulinumtoxinA from Revancehttps://modernaesthetics.com/news/fda-sets-november-pdufa-date-for-daxibotulinumtoxina-from-revance/2472880/FDA has accepted the Biologics License Application (BLA) for DaxibotulinumtoxinA for Injection (DAXI) in the treatment of moderate to severe glabellar (frown) lines, Revance reports. The FDA set an action date of November 25, 2020 under the Prescription Drug User Fee Act (PDUFA) VI program.
- Candela Launches Exceed Medical Microneedling Systemhttps://modernaesthetics.com/news/candela-launches-exceed-medical-microneedling-system/2472878/Candela Corporation has entered into an exclusive collaboration agreement with MT.DERM GmbH for the commercialization of MT.DERM's medical microneedling products. Under the terms of the agreement, Candela will commercialize the Exceed medical microneedling system globally, with a first launch